The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


State of the art: duration of dual antiplatelet therapy after percutaneous coronary intervention and coronary stent implantation – past, present and future perspectives

EuroIntervention 2017;13:717-733. DOI: 10.4244/EIJ-D-17-00468

1. Department of Cardiology, Bern University Hospital, University of Bern, Bern, Switzerland; 2. Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy; 3. Cardiac-Thoracic-Vascular Department, Ferrarotto Hospital, Uni

Evidence from studies published more than 10 years ago suggested that patients receiving first-generation drug-eluting stents (DES) needed dual antiplatelet therapy (DAPT) for at least 12 months. Current evidence from randomi

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
State of the art: the inception, advent and future of fully bioresorbable scaffolds